E-mail: info@tlph.com.la
Soranni (Sorafenib) is a kinase inhibitor drug approved for the treatment of primary kidney cancer (advanced renal cell carcinoma), advanced primary liver cancer (hepatocellular carcinoma), and radioactive iodine resistant advanced thyroid carcinoma.
Address: Rd.13 South, 31 km Ban Naphasuk,
SaithanyDistrict, Vientiane, Lao PDR 
E-mail: info@tlph.com.la 
WeChat: TLPH01 Whatsapp:+856 20 76 814 389 
Website: https: //tlph.com.la